Stryker invests $400M in CMR Surgical with option to acquire it

Stryker has invested about $400 million in CMR Surgical, with an exclusive option to acquire the rest of its equity. Stryker will also serve as the exclusive U.S. sales agent for the Versius surgical robot portfolio, while CMR continues to commercialize it elsewhere. The transaction is subject to regulatory approvals and customary closing conditions.